Graduated from Chongqing University majoring in Biomedical Engineering.

He engaged in R&D and management in Enwei Group and HEC Group before,and joined ImmVira in 2016 to fully manage the pre-clinical R&D departments and coordinate the interface between pre-clinical and clinical business. He has participated in preclinical research and development of oncolytic virus and engineered targeted exosome products.

He has more than 20 years of experience in drug development and toxicology research. He is responsible for and has participated in the preclinical research and development of several marketed drugs and has rich experience in R&D management.